Black Bird Biotech, Inc.

BBBT

US09183V1017

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 02:08:35 2024-04-26 pm EDT			5-day change	1st Jan Change
0.0001 ^USD	0.00%		-50.00%	0.00%

Apr. 16	Black Bird Biotech, Inc. Appoints Nelson Grist as New CEO	CI
Apr. 16	Black Bird Biotech, Inc. Appoints Nelson Grist as Its Future Member of Its Board of Directors	CI

Black Bird Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022

March 21, 2023 at 06:30 am EDT

Black Bird Biotech, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 0.082563 million compared to USD 0.104458 million a year ago. Net loss was USD 1.66 million compared to USD 1.81 million a year ago.

Latest news about Black Bird Biotech, Inc.

Black Bird Biotech, Inc. Appoints Nelson Grist as New CEO	Apr. 16	CI
Black Bird Biotech, Inc. Appoints Nelson Grist as Its Future Member of Its Board of Directors	Apr. 16	CI
Black Bird Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 20	CI
Black Bird Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-21	CI
Black Bird Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-22	CI
Black Bird Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-21	CI
Black Bird Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-21	CI
Black Bird Biotech, Inc. Auditor Raises 'Going Concern' Doubt	23-03-20	CI
Black Bird Biotech, Inc. announced that it expects to receive $5 million in funding from Mast Hill Management, LLC	22-12-12	CI
Black Bird Biotech Secures Distribution Agreement for Its MiteXstream Biopesticide	22-12-08	CI
Black Bird Biotech Hires XCPCNL Business Services Corporation to Boost Bee Tested, Bee Safe Mitexstream Biopesticide Sales Within Cannabis Industry	22-11-30	CI
Black Bird Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Black Bird Biotech To Formally Test MiteXstream Biopesticide for Capacity to Boost Plant Growth, Fruit Production, In Common Agricultural Crops	22-09-26	CI
Black Bird Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-23	CI
Black Bird Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-23	CI
Black Bird Biotech, Inc. announced that it has received $0.225 million in funding from Mast Hill Management, LLC	22-05-15	CI
Black Bird Biotech, Inc. announced that it expects to receive $0.225 million in funding from Mast Hill Management, LLC	22-05-11	CI
Black Bird Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-15	CI
Black Bird Biotech, Inc. Auditor Raises 'Going Concern' Doubt	22-04-14	CI
William J. Lobell Appoints as Executive Vice President of Sales and Development for Black Bird Biotech, Inc	22-04-12	CI
Black Bird Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-22	CI
Black Bird Biotech, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-23	CI
Black Bird Biotech Inc. has Changed its Ticker to BBBT from DGDM	21-06-14	CI
Digital Development Partners, Inc. will Change its Name to Black Bird Biotech, Inc	21-06-14	CI
Digital Development Partners, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-24	CI

Chart Black Bird Biotech, Inc.

Duration

Period

More charts

Company Profile

Black Bird Biotech, Inc. is a manufacturer and distributor for MiteXstream, an environmental protection agency (EPA)-certified plant-based biopesticide effective in the eradication of mites and other similar pests, including spider mites, that destroy crops, particularly cannabis, hops, coffee and house plants, as well as molds and mildew. The Company also manufactures and sells, under its Grizzly Creek Naturals brand name, cannabidiol (CBD) products, including CBD Oils, gummies and pet treats, as well as CBD-infused personal care products. Big Sky American Dist., LLC (Big Sky American) distributes its Grizzly Creek Naturals products, as well as an array of other consumer retail products, in Western Montana. The Company's subsidiaries include Black Bird Potentials Inc. (BB Potentials), Big Sky American Dist., LLC (Big Sky American) and Black Bird Hemp Manager, LLC.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
BLACK BIRD BIOTECH, INC.	0.00%	298K
DONG-E-E-JIAO CO.,LTD.	+35.04%	5.92B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.13%	4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD	-9.75%	3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+2.14%	3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-6.82%	2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+47.87%	1.97B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.89%	1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.09%	1.65B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.97%	1.53B